Skip to main content
Sri Yarlagadda, MD, Nephrology, Kansas City, KS

Sri G Yarlagadda MD


Associate Professor, Internal Medicine, University of Kansas School of Medicine

Join to View Full Profile
  • 4000 Cambridge StKansas City, KS 66160

  • Phone+1 913-588-1227

  • Fax+1 913-588-3867

Dr. Yarlagadda is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

Education & Training

  • Yale-New Haven Medical Center
    Yale-New Haven Medical CenterFellowship, Nephrology, 2005 - 2008
  • University of Connecticut
    University of ConnecticutResidency, Internal Medicine, 2002 - 2004
  • St Barnabas Hospital
    St Barnabas HospitalInternship, Internal Medicine, 2001 - 2002
  • M. Rampure Medical College
    M. Rampure Medical CollegeClass of 2000

Certifications & Licensure

  • MO State Medical License
    MO State Medical License 2021 - 2026
  • KS State Medical License
    KS State Medical License 2008 - 2025
  • CT State Medical License
    CT State Medical License 2007 - 2008
  • Internal Medicine
    American Board of Internal Medicine Internal Medicine
  • Nephrology
    American Board of Internal Medicine Nephrology

Awards, Honors, & Recognition

  • CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013
  • Young Investigator Award American Society of Hypertension-Eastern Chapter, 2004
  • Certificate of Merit in Medicine 1998
  • Join now to see all

Publications & Presentations

PubMed

Journal Articles

  • Metastatic Calcifications after parathyroidectomy in a dialysis patient  
    Munis Mattu and Sri G Yarlagadda, Nephrology, 1/1/2013
  • First Case of Donor Transmitted Non Leukemic Promyelocytic Sarcoma  
    Williams T, Aljitawi OS, Moussa R, McHugh S, Dusing R, Abraha J, Yarlagadda SG, Leuk Lymphoma, 1/9/2012
  • Blood group A isoagglutinins in A2-> O simultaneous liver/kidney transplantation may not influence kidney function  
    Bryan CF, Abdulkarim A, Nawabi A, Stewart A, and Yarlagadda SG, American Journal of Transplantation, 1/1/2011
  • Join now to see all

Abstracts/Posters

  • The influence of HLA Class 2 donor specific antibodies present at the time of renal transplantation on Early Graft Outcome
    Christopher Bryan, Aditi Gupta, Daniel Murillo, Connie Wang, Sri G Yarlagadda, Atta Nanwabi, Timothy Schmitt, American Transplant Congress, 1/1/2013
  • Urinary Cystatin C and KIM-1: A Tale of Two Novel Biomarkers of Acute Kidney Injury in Predicting the Need for Dialysis after Kidney Transplantation
    Sri G. Yarlagadda, American Transplant Congress Meeting, 1/1/2009
  • Urine NGAL and IL-18 are better markers of DGF compared to existing parameters.
    Sri G. Yarlagadda, American Society of Nephrology Meeting, 1/7/2008
  • Join now to see all

Other

  • Effect of diuretics on magnesium handling by the kidney. 
    Alan S L Yu, Sri G Yarlagadda, UpToDate
    1/1/2013
  • Clinical Manifestations of magnesium depletion. 
    Alan S L Yu, Sri G Yarlagadda, UpToDate
    1/1/2013
  • Parathyroid and Mineral Metabolism after renal transplantation. 
    Sri G Yarlagadda, David W Butterly, L Darryl Quarles, UpToDate
    1/1/2009

Viewing the full profile is available to verified healthcare professionals only.

Find your profile and take control of your online presence: